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Abstract.  We have studied the translocation of a nor- 
mally cytoplasmic protein domain across the mem- 
brane of the endoplasmic reticulum in cell-free sys- 
tems and in Xenopus laevis oocytes. Coding regions 
for the normally cytoplasmic protein globin were en- 
gineered in frame either 3' or 5' to the coding region 
for the signal sequence of either Escherichia coli 
b-lactamase or bovine preprolactin, respectively, in SP6 
expression plasmids. RNA transcribed from these 
plasmids was microinjected into oocytes as well as 
translated in cell-free systems. We demonstrate that 
both in vivo and in vitro, a previously amino-terminal 
signal sequence can direct translocation of domains 
engineered to either side.  Moreover, the domain 
preceding the signal sequence can be as large as that 
which follows it. While, in general, cell-free systems 
were found to faithfully reflect translocation events in 
vivo, our results suggest that a  mechanism for clear- 
ance of signal peptides after cleavage is present in in- 
tact cells that is not reconstituted in cell-free systems. 
rowing body of evidence suggests that translocation 
of newly synthesized secretory and membrane pro- 
teins across the endoplasmic reticulum membrane 
is directed by a  series of interactions between discrete se- 
quences within the nascent chains and receptors (1). The 
mechanism by which this occurs has been studied by two 
general approaches.  One approach used fractionation and 
reconstitution of translocation activity to  identify critical 
components. This approach led to the discovery of signal 
recognition particle  (SRP) ~ and the  SRP receptor and to 
elucidation of the phenomenon of elongation arrest (4, 5, 12, 
13,  18, 19, 22, 23, 25). A second approach involves the use 
of molecular genetic techniques to prepare plasmids encod- 
ing altered proteins which contain domains that direct the 
translocation process (i.e., signal and stop-transfer sequences) 
placed in an unusual location. This second approach has 
demonstrated that normally cytosolic proteins can be  re- 
directed to the endoplasmic reticulum lumen by a signal se- 
quence, that translocation can be uncoupled from transla- 
tion,  and  that  amino-terminal signal  sequences  have the 
intrinsic ability to direct translocation of  both amino and car- 
boxyl flanking domains (9,  15,  16). 
One limitation of both approaches has been that they were 
carried out in cell-free systems. To study translocation events 
in vivo, we decided to microinject Xenopus oocytes. They 
present several advantages for our purposes: large numbers 
of constructions can be rapidly introduced by microinjection 
of the same (unpurified) transcript that is used for cell-free 
translation studies  (3);  expression  is  sufficiently massive 
that, in many cases, the resultant translation products immu- 
noprecipitated  from  one  oocyte  labeled  with  [35S]methi- 
1. Abbreviation  used in this paper:  SRP,  signal recognition particle. 
onine for 1 h can be detected after a  1-d exposure following 
SDS PAGE and autoradiography; a variety of probes includ- 
ing RNA  (6),  antibodies (14, 21), cell fractions (17), and 
drugs (2) could potentially be rapidly introduced. 
As a first step towards corroborating and extending find- 
ings from cell-free systems, we have studied the translocation 
of globin domains in engineered fusion proteins. In one fu- 
sion protein, the globin domain is preceded by the signal se- 
quence for 13-1actamase, and in a second set of fusion pro- 
teins the globin domain itself precedes the signal sequence 
of preprolactin. Our results show that a signal sequence is 
sufficient  to direct translocation of  a cytoplasmic protein, and 
that preprolactin is capable of directing the translocation of 
both amino and carboxyl flanking domains in oocytes, thus 
extending our previous  findings in cell-free systems. Our 
results also show that, contrary to the results obtained in cell- 
free  systems,  the  signal  sequence  and associated amino- 
terminal  domain  generated  by  signal  peptidase  cleavage 
seems to be rapidly and preferentially degraded in oocytes. 
In contrast, the "passenger" domain from which the signal 
sequence has been cleaved, as well as residual full-length 
precursor in the cytosol, are longer-lived. 
These observations demonstrate that, in general, events 
observed  in  cell-free  systems are  a  faithful reflection of 
events occurring in living cells. However,  some additional 
translocation-related events not reconstituted in vitro may be 
assayed in Xenopus oocytes. 
Materials and Methods 
Materials 
Rabbit anti-human globin antisera was obtained from Cappel Laboratories, 
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Biochemical  Corp.,  Cleveland, OH.  All restriction endonucleases,  SP6 
RNA polymerase, T4 DNA ligase,  and Klenow  fragment of Escherichia 
coli, and DNA polymerase was from Boehringer Mannheim Diagnostics 
Inc., Houston,  TX, or from New England Biolabs, Beverly, MA. RNase 
inhibitor was from Promega Biotec, Madison, WI. Trypsin,  Trasylol,  and 
Proteinase K were from Boehringer Mannheim Diagnostics,  Inc., Piscata- 
way, NJ. Protein A-Sepharose was from Pharmacia Fine Chemicals,  Pis- 
cataway, NJ. Xenopus laevis frogs were obtained from Nasco, Fort Atkinson, 
Wl; [35S]methionine was from New England Nuclear,  Boston, MA; and 
hydroxyleucine  was from Calbiochem-Behring Corp., Torrance,  CA. 
Constructions 
All constructions were engineered into the pSP64 vector which was ob- 
tained from Promega Biotech.  A chimpanzee n-globin eDNA cloned into 
the Pst site of pBR322 was kindly provided by S. Liebhaber, University of 
Pennsylvania School of Medicine, Philadelphia, PA. This plasmid, pMCI8, 
was cut with Xmnl in the presence of ethidium bromide, followed by timed 
digestion  with Bal31, recut with Ncol, treated with Klenow fragment and 
T4 DNA ligase. From the resulting transformants a perfect fusion of the lac- 
tamase signal sequence with the initial methionine of globin was recovered 
and subcloned into pSPIM as a Hind III-Pst I fragment. This plasmid was 
termed pSP125E. PSPG1E was derived from pSP125E by deletion of  the sig- 
nal sequence coding region and a portion of 5' untranslated region as a result 
of cleavage with Bg HI,  Nco I, treatment with Klenow fragment, and T4 
DNA ligase. Details for the pSPGP1 construction can be found in reference 
14. PSPG2P was derived from pSPGP1 by subeloning a BssH II-BstE II 
fragment containing two globin coding regions into the BssH II-BstE II sites 
of pSPGP1. 
In Vitro Synthesis of  Capped Transcripts 
Cesium-purified  plasmids were linearized at sites in the 3' untranslated re- 
gion, extracted in phenol/chloroform, ethanol precipitated,  and dissolved in 
water. Transcription was carried out in 10-gl volumes containing 2.5 gg lin- 
earized DNA, 20 U SP6 polymerase,  0.25 mg/ml calf liver tRNA, 0.5 mM 
ATP, 0.5 mM CTP, 0.5 mM UTP, 0.1 mM GTE 0.5 mM GpppG (caps), 
10 mM dithiothreitol,  2 mM spermidine,  6 mM MgCI2, 40 mM Tris-Cl, 
pH 7.5, and 0.9 U/ul human placental RNase inhibitor. Reactions were car- 
tied out at 40°C for 1 h and aliquots of total reaction mix were used directly 
for injection or in vitro translation. 
Cell-free Translation 
4-BI aliquots of total transcription products were added to translation reac- 
tions of 20-ttl vol containing 8.6 BI of rabbit reticulocyte lysate prepared as 
described (11), 1 mCi/ml  [35S]methionine, 0.2 mM each of the other 19 
amino acids, methionine, 16 mM Tris-HCl (pH 7.5),  100 mM KCI, 2 mM 
MgCI2, 0.44 mM spermidine,  2 mM dithiothreitol, 0.9 mM GTP, 1 mM 
ATP,  10 mM creatine phosphate, 0.4 mg/ml creatine phosphokinase,  0.1 
mg/ml calf liver tRNA. Reaction mixtures were incubated at 24°C for 60 
rain in the absence or presence of 2 U/mi dog pancreas rough microsomes 
(prepared  as described, reference 24). 
Posttranslational Protease Protection 
After a 1-h incubation at 24°C in the presence of membranes, translation 
reaction mixtures were  chilled on ice,  adjusted to  10 mM CaCI2, and 
divided into equal aliquots of 5 or 10 gl. Some were treated with proteinase 
K (dissolved in 10 mM CaCI2, 50 mM Tris [pH 7.5], and preincubated at 
37°C for 15 min) at a final concentration of 0_3 mg/ml either in the presence 
or absence of 1% Nikkol  (a nonionic detergent  used to disrupt the lipid 
bilayer).  Proteinase  digestion  was  stopped  by  the  addition  of  2  mM 
phenylmethylsulfonyl  fluoride  (PMSF)  and  samples  were  immediately 
transferred to 4-5×  vol  1% SDS in 0.1  M Tris-HCl (pH  8.9) preheated 
to 100°C, then incubated at 100°C for 10-15 rain. Samples were diluted 20- 
fold in a solution of 1% Triton,  0.1 M Tris-HCI (pH 8.0),  10 mM EDTA, 
1(30 mM  NaCI,  subjected  to  immunoprecipitation  with  either 0.5  gl 
anti-prolactin antiserum or 4 gl anti-globin antiserum and protein A-Seph- 
arose-CL4B,  followed by SDS PAGE. 
Microinjection of  Xenopus Oocytes 
Xenopus oocytes were manually dissected and were subsequently injected 
and  labeled  in  modified  Barth's  saline  solution  (MBSH)  containing 
[3SS]methionine as  described  (6,  20).  MBSH  contains  88  mM  NaCI, 
i mM KC1, 2.4 mM NaHCO3,  0.82 mM MgSO4, 0.33  mM Ca (NO3)2, 
0.41 mM CaCI2, 10 mM Hepes  (pH 7.6). 
Immunoprecipitation of  Oocyte Translation Products 
Medium and oocytes were separated,  and the medium was then diluted in 
4× vol Buffer A (1% Triton X-100, 0.1 M Tris-HCl (pH 8.0), 0.1 M NaCI, 
0.01 M EDTA,  1 mM PMSF); oocytes were homogenized  in 20 gl/oocyte 
of Buffer A. 2-10 ILl antisera was added to each sample,  and samples were 
incubated overnight at 4°C. After incubation, samples were centrifuged  in 
an Eppendorf centrifuge  at 10,000 g for  1 min to remove aggregates,  and 
the supernatants  were then transferred  to a fresh tube containing 15 I.tl of 
a 50% slurry of protein A-Sepharose in Buffer A. Samples were incubated 
for 1 h at 4°C,  washed three times with Buffer A, and twice subsequently 
with buffer containing 0.1 M Tris-HC1 (pH 7.5) and 0.1 M NaCI to remove 
residual  Triton. 
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Figure 1. Line diagrams of relevant regions of SP6 expression plas- 
raids.  Restriction  maps of plasmids are indicated  above the lines 
and defined coding regions by the bars below. The SP6 promoter 
is indicated by the small solid black box, denoted SP6p.  pSPG1E 
encodes full-length chimpanzee ¢t-globin (143  amino acids; open 
bar). pSPBP3  encodes full-length bovine preprolactin; the signal 
sequence is represented by the solid black bar and mature prolactin 
by the cross-hatched bar. pSP125E encodes a perfect fusion of the 
13-1actamase  signal  sequence  (stippled bar) joined  to  the  initial 
methionine of full-length chimpanzee a-globin (open bar). pSPGPI 
encodes a fusion protein of the first 109 amino acids of chimpanzee 
tt-globin (open  bar)  followed  by  full-length bovine preprolactin 
such that the signal sequence of preprolactin (solid black box)  is 
flanked on the amino terminus by globin and on the carboxy termi- 
nus by mature prolactin (cross-hatched  bar). pSPG2P is identical 
to pSPGP1 except that it encodes the first 109 amino acids of globin 
fused to amino acids 21-109 of globin (open bar) followed by full- 
length preprolactin. In subsequent figures, the full-length encoded 
products are described with the prefix "pre" (e.g., pre-GSP and pre- 
G2SP), and the products of signal cleavage are described according 
to their corresponding coding regions (e.g.,  P1,  GS1,  and G2SI). 
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of  pSP125E.  Transcription- 
linked wheat germ translations 
programmed  with  pSP125E 
were carried out as described 
in Materials and Methods. Re- 
actions were carded out either 
in the absence (lanes A and B), 
or presence (lanes C-E) of dog 
pancreas  rough  microsomes. 
Some  samples  were  subse- 
quently treated with trypsin in 
the absence (lane D) or pres- 
ence (lane E)  of 1%  Triton. 
Samples were immunoprecip- 
itated with anti-globin  antise- 
rum (lanes  B-E),  or nonim- 
mune serum (lane A), subjected to SDS PAGE, and viewed by auto- 
radiography.  Downward-pointing  arrowheads indicate the  signal 
sequence-containing  precursor,  pre125E; upward-pointing  arrow- 
heads indicate the processed molecule, 125E, from which the signal 
sequence has been cleaved. 
Pulse-Chase 
Oocytes were injected with in vitro-synthesized  transcripts, preincubated 
for 5 h, and pulse-labeled  for 1 h in MBSH containing  5 mC/ml 3SS-met. 
Labeled medium was then removed, oocytes were briefly washed in cold 
MBSH, and then incubated  for varying  lengths  of time in MBSH containing 
10% fetal calf serum and 20 mM unlabeled  methionine. 
Subcellular Fractionation of  Injected Oocytes 
Freshly labeled  oocytes were homogenized  with 40 ~tl/oocyte  at 4°C in an 
isoosmotic buffer  containing  10% (wt/vol) sucrose, 150 mM NaCI, 10 mM 
MgAc, 20 mM Tris-HCl (pH 7.6) (Buffer B). 500 gl of total homogenate 
was layered over a bml cushion of 20% sucrose (wt/vol), 50 mM NaCl, 
10 mM MgAc, 20 mM Tris-Ci (pH 7.5) (Buffer C), and spun at 15,000 g 
for 30 min in the ultracentrifuge.  The top 500 lal (cytosolic components) 
was removed, the rest of the supernatant  aspirated, and the pellet (vesicles) 
resuspended in Buffer A. 
Proteolysis of Oocyte Vesicles 
Freshly labeled oecytes were homogenized with a ground glass homog- 
enizer in 40 I~l/ooeyte  of Buffer B. Each sample was divided into three ali- 
quots: the first aliquot  was a control with no added protease, and the other 
two aliquots were treated with 0.3 mg/ml Proteinase  K in the presence or 
absence  of 1% Triton  X-100. All samples  were incubated  for 3 h at 40C. Pro- 
tease digestion  was stopped by the addition  of 2 mM PMSF followed  by boil- 
ing in 2× vol 2% SDS in0.1 M Tris-Cl (pH 8.9) for 15 min. Samples  were 
then diluted  20-fold in a solution  of I% Triton,  0.02 M Tris (pH 8.0), 2 mM 
EDTA, 20 mM NaC1, and subjected  to immunoprecipitation  followed  by gel 
electrophoresis. 
Results 
We have previously shown that the lactamase signal sequence 
together with the first five amino acids of authentic lactamase 
is sufficient  to direct globin to the lumen of microsomal vesi- 
cles in cell-free systems (9). We initiated the present study 
by extending these initial observations using a construct en- 
coding a perfect fusion between the signal and globin coding 
regions placed behind the SP6 promoter (pSP125E). 
Fig. 1 displays line diagrams of the relevant coding regions 
for plasmid pSP125E and other plasmids studied here. RNA 
was transcribed from this plasmid using SP6 polymerase, 
and was translated in a  wheat germ cell-free system in the 
Figure 3. (a) Subcellular tractionation  and proteolysis of G1E (globin) and BP3 (prolactin) in Xenopus oocytes. Oocytes were injected with 
SP6 transcripts of pSPG1E (lanes A, B, E-G) or pSPBP3  (lanes C, D, H-J), labeled with [35S]methionine, and vesicles prepared as de- 
scribed. Cytosolic (lanes A and C) and vesicle (lanes B and D) fractions were separated  as described. Some samples were assayed by 
protease protection (lanes E-J). Samples were incubated in the absence (lanes E and H) or presence (lanes F, G, L and J) of proteinase 
K, some with 1% Triton (lanes G and J) added. Samples were immunoprecipitated either with anti-globin  (lanes A, B, E-G) or antiprolactin 
(lanes C, D, H-J) antiserum and subjected to SDS PAGE. Gels were fluorographed,  and bands were visualized by autoradiography. Large 
arrowheads indicate mature prolactin and small arrowheads indicate globin. (b) Expression and subcellular  localization of 125E in Xenopus 
oocytes. Oocytes were either injected with pSPI25E transcripts (lanes A, B, E-l) or were not injected (lanes C and D) and subsequently 
labeled for  1 h as described. Some of the injected oocytes were separated  into cytosolic (lane E) and vesicle fractions (lane F). Other 
injected oocytes were homogenized in isoosmotic buffer and were subsequently  treated with proteinase K in the absence (lane H) or presence 
(lane I) of detergent,  or were untreated  (lane G),  as  described in Materials  and Methods.  Samples  were  immunoprecipitated with 
anti-globin serum (lanes A,  C, E-I) or nonimmune serum (lanes B and D), analyzed by SDS PAGE, and viewed by autoradiography. 
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from dog pancreas. In the absence of membranes, a single 
globin-immunoreactive product  (termed  pre125E),  which 
was of higher molecular weight than authentic globin, was 
observed (Fig. 2,  lane B). In the presence of membranes, 
an additional giobin-immunoreactive band (termed 125E), 
which co-migrated with authentic globin, was observed (Fig. 
2, lane C). To determine the localization of  these two protein 
species, proteases were added after completion of transla- 
tion. Pre125E was localized outside of the microsomal vesi- 
cle (i.e., in the topologic equivalent of the cytosol), since it 
was degraded by added proteases. However, 125E was quan- 
titatively protected from protease (Fig.  2,  lane D)  unless 
nonionic detergent was  added to  solubilize the protecting 
lipid bilayer (Fig. 2, lane E), thus indicating the microsomal 
vesicle lumen as its location. 
To determine the subcellular localization of 125E in vivo, 
transcripts were microinjected into Xenopus oocytes. Con- 
trol  oocytes were co-injected with  transcripts  encoding a 
cytosolic protein (G1E,  authentic full length globin without 
a  signal  sequence) and a  normally secreted protein (BP3, 
full-length preprolactin). Fig. 3 a shows that after subcellu- 
lar fractionation, G1E was localized to the cytosol (lanes A 
and B), whereas BP3 was in the vesicle fraction (lanes Cand 
Figure 4. Cell-free transiatlon of pSPG2P, pSPG2P was used as a 
template for SP6 polymerase and the resulting RNA was used to 
program cell-free translation in rabbit reticulocyte lysate. Transla- 
tion reactions were carded out in the absence 0aries A and B) or 
presence (lanes C-H) of dog pancreas microsomes. Aliquots of 
translation product were incubated with proteinase K 0aries B, D, 
E, G, and H), some with Triton added (lanes E and H); or with 
no additions (lanes A,  C, and F) as described  in Materials and 
Methods.  Samples were immunoprecipitated with anti-prolactin 
(lanes A, B, F-H) or anti-globin (lanes C-E) serum and analyzed 
by SDS PAGE followed by autoradiography. Downward-pointing 
arrowheads  indicate  the  precursor,  preG2SP. Small  upward- 
pointing arrowheads in lanes C and D indicate G2S1 and in lanes 
F and G indicate P1. The dot alongside lane D denotes minor con- 
taminants of P1 in samples immunoprecipitated with anti-globin 
serum. 
D). When injected oocytes were homogenized in an isoos- 
motic  buffer and  subsequently  incubated  with  proteinase 
K, G1E  was  completely degraded  (Fig.  3  a,  lanes E-G), 
whereas BP3 was completely protected from digestion (Fig. 
3 a,  lanes H-J).  When pSP125E transcripts were injected 
into Xenopus oocytes, a single globin-immunoreactive prod- 
uct  was  observed after  a  1-h  pulse  with  [35S]methionine 
(Fig. 3 b, lane A). Neither nonimmune control precipitations 
(Fig. 3 b, lanes B and D), nor anti-globin immunoprecipita- 
tion of mock-injected oocytes (Fig.  3  b,  lane D)  demon- 
strated globin-immunoreactive products under these condi- 
tions.  This  product,  which  co-migrated  with  125E,  was 
demonstrated by cell fractionation to be located quantita- 
tively in the vesicle fraction of the oocyte (Fig. 3 b, lanes E 
and F).  Moreover, proteolysis demonstrated that,  like its 
cell-free counterpart (see Fig. 2), the mature 125E product 
was localized to the vesicle lumen (Fig. 3 b, lanes G-I). We 
conclude that both in intact cells and in cell-free systems, an 
amino-terminal signal sequence is sufficient to direct a nor- 
mally cytoplasmic protein across the endoplasmic reticulum 
membrane. Elsewhere we will demonstrate that this mature 
globin localized to the ER lumen can be transported through 
the secretory pathway and secreted into the medium (Simon, 
K., and V.  R.  Lingappa, manuscript in preparation). 
Having established that a simple substrate displays similar 
translocation behavior in vitro and in vivo, we studied more 
complex constructions.  Recently,  we engineered a  globin 
coding region 5' to the normally amino-terminal signal se- 
quence of bovine prolactin. Plasmid pSPGP1 encodes a fu- 
sion  protein comprised of the  initial  109  amino  acids  of 
globin followed in frame by the signal sequence (30 amino 
acids) and the entire coding region of bovine prolactin (199 
amino acids).  When pSPGP1  was expressed in a  cell-free 
transcription-translation system, the former amino-terminal 
prolactin signal sequence still directed translocation of the 
prolactin domain with concomitant cleavage of the signal se- 
quence (15). Moreover, the globin domain flanking the signal 
on the amino terminus was also translocated, albeit with ap- 
parent reduced efficiency. 
To extend these studies, we constructed a similar chimeric 
protein in which part of a second globin-coding region was 
engineered into that of pSPGP1. This new plasmid, pSPG2P, 
encoded 250  amino acids  of globin  (parts of two globin- 
coding regions arranged in tandem) followed by the prepro- 
lactin signal sequence (30 amino acids) and mature prolactin 
(199 amino  acids)  (see  Fig.  1).  When  expressed  in  the 
transcription-linked translation system from reticuloevte Iv- 
sate, a single polypeptide of  45,000 D, termed preG2SP, was 
observed (Fig. 4, lane A); this protein was both globin and 
prolactin immunoreactive (Fig. 4, lanes A, C, and F). when 
membranes were present during translation, two new prod- 
ucts  were  observed.  One  of these  membrane-dependent 
products,  termed G2S1,  was  globin but not prolactin im- 
munoreactive, and this peptide was the predicted size for the 
globin domains joined to the signal sequence (Fig. 4, lane 
C).  The other product,  termed P1,  was prolactin but not 
globin immunoreactive, and it co-migrated with mature bo- 
vine prolactin (Fig. 4, lane F). Digestion with protease re- 
vealed that, as observed previously with GS1 (15), some, but 
not all, G2S1 chains were protected from protease in the ab- 
sence of detergent (Fig. 4, lane D). In the same aliquot, es- 
sentially all P1 chains were protected from protease in the 
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ation of G2P expressed in Xe- 
nopus oocytes. Oocytes were 
injected  with  pSPG2P  tran- 
scripts, preincubated  overnight, 
and then labeled for 6 h with 
[35S]methionine as described. 
Groups of 10 injected oocytes 
were  homogenized in  isoos- 
motic  buffer  and  separated 
into a cytosolic (lanes A and 
C) and vesicle (lanes B and D) 
fraction. Each fraction was im- 
munoprecipitated  with  anti- 
globin (lanes A and B) or an- 
ti-prolactin  (lanes  C and D) 
antiserum, respectively. Sam- 
ples were analyzed by SDS PAGE, and viewed by autoradiography. 
Downward-pointing arrowheads refer to preG2SP; small upward- 
pointing arrowheads refer to chains migrating to the position of 
authentic prolactin in lanes C and D and to the immunoreactive glo- 
bin fragments generated from cleavage of the signal sequence in 
lanes A and B. 
Figure 5.  Expression of pSPGP and pSPG2P in Xenopus oocytes. 
Groups of eight oocytes were injected with pSPGP (lanes A and B) 
or pSPG2P (lanes C and D) transcripts, preincubated overnight, 
and labeled for 3 h with  [35S]methionine  as described.  Oocytes 
were then homogenized in Buffer A, and each set was divided into 
two aliquots which were immunoprecipitated with anti-prolactin 
(lanes A and C) or anti-globin (lanes B and D) serum, respectively. 
Downward-pointing arrowheads indicate preGSP  and preG2SP; 
smaller upward-pointing arrowheads indicate peptides migrating to 
the position of authentic prolactin in lanes A and C, and indicate 
immunoreactive globin fragments generated from cleavage of the 
internal signal sequence in lanes B and D. Much larger amounts of 
precursor are observed in lanes B and D as compared with lanes 
A and C because  10x vol was used in lanes B and D in order to 
visualize the faint globin-immunoreactive bands. 
absence of detergent (Fig. 4, lane G). Thus, enlarging the 
domain preceding the signal sequence appeared to have little 
effect on either promoting or preventing translocation of that 
domain.  These  results  have  been  reconfirmed  by  using 
glycosylated domains (15). 
These results suggest that translocation of a single globin 
domain engineered 5' to a signal sequence was not a fortui- 
tous result limited to domains of a narrow range of sizes. To 
determine whether the unusual translocation events which 
were consistently observed in cell-free systems also occurred 
in  intact cells,  pSPGP1  and pSPG2P transcripts  were ex- 
pressed in Xenopus oocytes. 
Oocytes were  injected with  transcripts  of pSPGP1  and 
pSPG2P, and after an overnight preincubation to allow for 
equilibration of RNA, they were continuously labeled with 
[35S]methionlne  for 3  h.  Newly synthesized products were 
immunoprecipitated with either anti-prolactin (Fig. 5, lanes 
A and C) or anti-globin (Fig. 5, lanes B and D) serum and 
analyzed by SDS PAGE. Immunoreactive bands correspond- 
ing to the translation products in cell-free systems were ob- 
served. In contrast to previous cases (e.g., 125E and prolac- 
tin, see Fig. 3), the products expressed in oocytes from both 
pSPGP1  and pSPG2P included full-length precursor (pre- 
GSP and preG2SP). These results demonstrate that although 
oocytes are highly efficient at translocation of correctly tar- 
geted chains,  full-length precursors can be detected when 
translocation efficiency is sufficiently perturbed. 
The localization of  products was first assessed by cell frac- 
tionation,  which revealed that P1  and G2S1  were predom- 
inantly associated with vesicles, whereas the preG2SP pre- 
cursor was localized predominantly to the cytosol (Fig. 6). 
Localization was also studied by protease protection assay. 
Consistent  with  the  expectations  from cell  fractionation, 
preG2SP was almost completely degraded, whereas P1 was 
protected from proteases unless  nonionic detergents were 
added to disrupt the protecting lipid bilayer (Fig.  7, lanes 
A- C). As in cell-free systems, some G2S1 chains were seen, 
which were partially protected (Fig. 7, lanes D-F); quantita- 
tive densitometry revealed that 20-30 % of total G2S1 chains 
were protected.  Similar cell fractionation and  proteolysis 
results were obtained when transcripts of pSPGP were ex- 
pressed in oocytes (data not shown).  Thus,  when a previ- 
ously amino-terminal signal sequence is engineered to an in- 
terual location, both flanking domains can be translocated 
across the endoplasmic reticulum membrane in cell-free sys- 
tems and in vivo. 
In contrast to our results in cell-free systems, where the 
GS1  (15) and G2S1  chains (Fig. 4) were generated in a  1:1 
ratio with P1, much less GS1 and G2S1 than P1 was detected 
in oocytes (see Fig. 5). Densitometric quantitation corrected 
for methionine content showed that  the globin-containing 
chains we detected represented only 10% of the amount ex- 
pected if each prolactin molecule had been generated from 
a peptidase-cleaved full-length precursor. One possible ex- 
planation  for  the  non-stoichiometric  amounts  of  globin- 
containing and prolactin chains seen in oocytes is that trans- 
lation  had  actually  initiated  from  an  internal  methionine 
present at the junction between the globin and preprolactin 
domains.  If this  were the case,  P1  over-expression would 
simply reflect a preference for initiating translation at the in- 
ternal rather than the initial AUG. To test this possibility, in- 
jected oocytes were incubated in the presence of hydroxyleu- 
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cytes were injected with pSPG2P transcripts  and then labeled for 
6  h  with  [35S]methionine as  described.  Labeled  oocytes  were 
homogenized in isoosmotic buffer and digested with proteinase K 
in the absence (lanes B and E) or presence (lanes C and F) of 1% 
Triton; lanes A and D show total products in the absence of  proteol- 
ysis. Each sample was then divided into two aliquots, and one set 
was immunoprecipitated with anti-prolactin  (lanes A-C), and the 
other with anti-globin  (lanes D-F) serum. Samples were analyzed 
by SDS PAGE and viewed by autoradiography. Downward-pointing 
arrowheads  refer to G2SP;  upward-pointing arrowheads  refer to 
chains migrating to the position of authentic prolactin (lanes A-C) 
or to immunoreactive globin  fragments (lanes D-F). Equivalent 
amounts of oocyte products were used for lanes A-C and D-F; how- 
ever, the former lanes were from a shorter exposure, to avoid over- 
exposure of the prolactin-reactive bands. 
results of a  pulse-chase experiment in  which  all products 
generated from both fusion proteins were followed through 
time. Whereas the amounts of precursor and mature prolac- 
tin (localized to the cytosol and secretory pathway, respec- 
tively) remained relatively constant, both the GS1 and G2S1 
chains were rapidly degraded with a half-time of '~30 min. 
Consistent with these observations, P1 (but not GS1 or G2S1 
fragments) can be detected in the incubation medium after 
a  long chase  (data  not  shown).  At least one  event  (rapid 
degradation),  apparently  specific  for  cleaved  signal  se- 
quences and their associated domains is not reconstituted in 
our cell-free systems. We suggest that this process, detected 
by the use of engineered probes with lengthened signal-as- 
sociated domains, may reflect the normal metabolism of sig- 
nal sequences after cleavage. 
Discussion 
We initiated these experiments for several reasons. First, we 
wished to extend our earlier results which suggested that, 
when placed in  an internal  location,  a  previously amino- 
terminal  signal  sequence  could direct the  translocation of 
both amino- and carboxy-terminal domains.  In the present 
cine, a leucine analogue which is incorporated into nascent 
chains;  the presence of hydroxyleucine prevents transloca- 
tion and signal cleavage by inhibiting the interaction of the 
signal sequence with SRP (8, 25). If signal cleavage of GP1 
and G2P were abolished, this should result in the disappear- 
ance of P1  and the appearance of the true precursor from 
which the P1 chains were generated. Fig. 8 shows the results 
of this experiment. Injection of hydroxyleucine into oocytes 
that  had  been preinjected  with  pSPGP1  or pSPG2P  tran- 
scripts abolished the P1 product and resulted in accumulation 
of larger amounts of the precursors, preGSP and preG2P; no 
additional products were observed (Fig. 8, lanes C-F). Simi- 
lar treatment of oocytes expressing bovine preprolactin tran- 
scripts resulted in disappearance of mature prolactin and an 
accumulation of preprolactin (Fig. 8, lanes A and B). There- 
fore, the nonstoichiometry of G2S1 or GS1 and P1 observed 
in oocytes was not a  result of initiation at an internal  site. 
An alternative explanation for the disproportion between 
P1  and GS1  or G2S1  chains detected  is that an equivalent 
number ofprolactin and globin-containing domains were ini- 
tially  generated,  and  that  the  GS1  and  G2S1  chains  were 
selectively recognized  due  to  the  presence of the  cleaved 
signal  and were subsequently degraded.  Fig.  9  shows  the 
Figure 8. Expression of BP3, GE and G2P in oocytes subsequently 
injected with hydroxyleucine. Groups of 10 oocytes were injected 
with pSPBP3 (lanes A and B), pSPGP (lanes Cand D), or pSPG2P 
(lanes E and F) transcripts and preincubated overnight. Each group 
of oocytes was then divided into one set which was injected with 
[3SS]methionine (lanes A, C, and E), and a second set which was 
injected with [35S]methionine diluted into 0.25 M hydroxyleucine 
(B, D, and F); oocytes were then incubated for 5 h in MBSH. La- 
beled oocytes were homogenized in buffer containing Triton and 
immunoprecipitated with anti-prolactin  antiserum.  Large, down- 
ward-pointing  arrowheads  refer  to the precursors,  preprolactin, 
preGSP, and preG2SP; small, upward-pointing arrowheads refer to 
chains migrating to the position of authentic prolactin.  Note that 
peptides synthesized in the presence of hydroxyleucine (lanes B, D, 
and F) migrate to a slightly higher position; this is due to the incor- 
poration of hydroxyleueine which has a higher molecular weight 
than its leucine analogue. 
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Figure 9. Pulse-chase of G2P and GP translation 
products in Xenopus oocytes. Groups of oocytes 
were injected with G2P (A) or GP (B) transcripts, 
labeled for  1 h  in  pSS]methionine, and  subse- 
quently chased in medium containing  20 mM unla- 
beled  methionine for  varying periods of time. 
Squares indicate preGSP and preG2SP, crosses in- 
dicate PI chains which migrate to the same posi- 
tion  as  mature  prolactin, and  circles indicate 
signal-associated,  globin-immunoreactive  GS1 
and G2S1 chains. 
study, we show that this phenomenon occurs even when the 
domain which precedes the signal is the same size as that 
which follows it.  Second, we wished to corroborate these 
surprising findings in vivo in order to rule out the possibility 
that the observed translocation reflected a  permissiveness 
unique to cell-free systems. Results presented here demon- 
strate that such internalized signal sequences can function to 
translocate both flanking domains in intact cells. It should be 
noted that the experiments presented here show yields and 
not rates of assembly, since translocation into the endoplas- 
mic reticulum can occur posttranslationally (16, 17, 26). 
In  addition  to  addressing  these  questions,  this  study 
yielded some unexpected findings. Cell-free systems typi- 
cally yield incomplete conversion of nascent precursors to 
processed authentic chains. This is in contrast to the lack of 
observed precursor in living cells and tissues and has been 
presumed to reflect inefficiency of signal-receptor recogni- 
tion in a fractionated, heterologous system. Consistent with 
this interpretation, increase in the concentration of available 
receptors  (by adding increasing membrane concentration) 
results in increased efficiency of translocation in vitro (10). 
Investigation of these phenomena in Xenopus oocytes has 
been revealing. We have detected precursors in oocytes, and 
this observation establishes the Xenopus oocyte as an in vivo 
system in which probes  of translocation might be studied 
with greater sensitivity by measuring changes in the relative 
amounts of precursor and products which accumulate. Thus, 
it might be possible to approach directly such previously in- 
accessible problems as the role of SRP-mediated elongation 
arrest in vivo by microinjection of SRP. 
The finding that signal-bearing cleavage fragments were 
grossly under-represented in oocytes was at variance with 
the results from cell-free systems. Since full-length precur- 
sor and full-length globin appeared reasonably stable in the 
cytosol, and processed  125E (globin),  as well as mature 
prolactin, appear stable in the endoplasmic reticulum lumen 
and secretory pathway, we suspect that the extremely rapid 
degradation of the processed signal-containing globin do- 
mains reflects a fate peculiar to signal-containing cleavage 
fragments. However,  we cannot exclude the possibility that 
the instability of GSl and G2S1 may be caused by their in- 
ability to be completely translocated across the endoplasmic 
reticulum membrane. 
Signal  sequences  are  generated stoichiometrically with 
secretory and membrane proteins, and in some tissues spe- 
cialized for secretion (pituitary or pancreas, for example) the 
quantities of stored secretory product constamtes a large per- 
centage of total cell protein,  thus it seems likely that an 
efficient mechanism for clearance of cleaved signal sequences 
might exist. Attempts to study the fate of cleaved signal pep- 
tides have been hampered by the difficulty in detecting the 
small, hydrophobic, cleaved peptide.  For this reason, the 
true fate of cleaved signal sequences has remained largely 
an unsolved problem. By joining a passenger domain to the 
amino terminus of a signal sequence, the size of the resultant 
cleaved, signal-bearing domain has been greatly increased. 
Moreover, the globin domain now serves to identify the frag- 
ment such that it can be immunoprecipitated and easily de- 
tected by standard SDS PAGE. While we cannot rule out the 
possibility that such engineering has altered the fate of the 
cleaved signal itself, the distinctive kinetics of degradation 
of the two different signal-bearing cleavage fragments com- 
pared to even the same domains when part of a full-length 
precursor  suggests  that  the  rapid  degradation  of signal- 
bearing  globin fragments occurred by a  mechanism nor- 
mally used for signal degradation. Our findings provide the 
basis for an assay in which we can attempt to localize the sig- 
nal clearance machinery by reconstituting these events in 
vitro using oocyte cell fractions. 
To date, most progress in defining the mechanisms of tar- 
geting to and translocation across the endoplasmic reticulum 
membrane derives from studies in cell-free systems. While 
the results of this study reconfirm that the translocation be- 
havior of altered substrates in cell-free systems is largely 
faithful to the corresponding events in vivo, our results iden- 
tify at least one translocation event which cannot be studied 
in currently available  cell-free systems; namely, the fate of 
cleaved  signal  sequences.  Xenopus  oocytes  programmed 
with the engineered substrates described here and in con- 
junction with appropriate antibodies should permit elucida- 
tion of this issue. Studies are in progress to exploit these and 
other implications of engineered substrate function in Xeno- 
pus oocytes. 
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